Veracyte | VCYT - Ebitda





Ebitda Veränderung Datum
Agenus USD -10.11M 19.02M 2025-03
Agilent USD 456M 84M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Bruker USD 110M 101.6M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Illumina USD 469M 137M 2025-12
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Laboratory Of America USD 605.6M 17.5M 2026-03
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 12.68B 2.36B 2024-06
Siemens EUR 3.56B 80M 2026-03
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veracyte USD 42.8M 488K 2026-03
Waters USD 380.97M 85.83M 2025-12